BioSpace News Archive

Biotech Bay

Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

Sutro Biopharma, Inc. today announced that Bill Newell , Chief Executive Officer, will participate in the 2021 Wells Fargo Securities Healthcare Conference during a virtual fireside chat on Thursday, September 9, at 3:20 p.m. ET / 12:20 p.m. PT.

September 1, 2021
·
3 min read
Biotech Bay

Asher Bio Closes $108 Million Series B Financing

Asher Biotherapeutics today announced the closing of an oversubscribed Series B financing, which raised $108 million.

September 1, 2021
·
5 min read
Business

Ribon Therapeutics Announces Key Management Promotions

Ribon Therapeutics today announced the promotions of Heike Keilhack, Ph.D., to Chief Scientific Officer and Kevin Kuntz, Ph.D., to Chief Drug Development Officer.

September 1, 2021
·
3 min read
BioCapital

Spire Global to Participate at Upcoming RBC Capital Markets Global Industrials Virtual Conference

Spire Global, Inc announced today that it is attending the RBC Capital Markets Global Industrials Virtual Conference and that CEO Peter Platzer, will participate in a fireside chat to be held virtually on Friday, September 10 at 10:00 AM ET.

September 1, 2021
·
1 min read
Business

IceCure Medical Announces Exclusive Distribution Agreement to Sell ProSense™ Cryoablation System in Turkey

IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing, today announced it has entered into an initial distribution agreement with Mutlu Medikim Tibbi Malzeme TIC. A.S.

September 1, 2021
·
4 min read
Pharm Country

Onkos Surgical Raises $15 Million in Series C Funding

Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, announced that it has raised $15 million in Series C funding from its existing investor syndicate.

September 1, 2021
·
4 min read
Pharm Country

INOVIO to Present at Upcoming Investor Conferences in September 2021

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced that Dr. J. Joseph Kim, President and CEO, will present at the following investor conferences in September:.

September 1, 2021
·
5 min read
Bio NC

IQVIA Launches New A.I.-Powered MI Contact Center For Life Sciences

IQVIA™ (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced it has added new AI-powered technologies to enhance its existing Medical Information (MI) Contact Center services.

September 1, 2021
·
3 min read
Bio NC

Asensus Surgical Receives FDA 510(k) Clearance for Expansion of Machine Vision Capabilities

Asensus Surgical , Inc. today announced that it has received 510(k) clearance from the FDA for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™).

September 1, 2021
·
7 min read
Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery

Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery

September 1, 2021
·
9 min read